Pembrolizumab Plus CCRT Improves Overall Survival
Adding pembrolizumab to standard concurrent chemoradiotherapy significantly improves overall survival in patients…
Eli Lilly’s Eczema Drug Gets FDA Approval, Injectable Treatment Available Within Weeks
The U.S. FDA has approved Eli Lilly's new eczema drug, Lebrikizumab branded…
Not Your Average Bra: How Bloomer Tech’s Wearable Is Addressing Heart Disease in Women
Wearable technology has become smaller and more comfortable, but it may have…
You might be interested in…Cardiology and Heart Disease
Dr. Ray O'Connor reviews the latest clinical papers on cardiology and heart…
Apple receives FDA clearance for sleep apnea and hearing aid technology
Apple has received FDA clearance for new features in its Watch Series…
Decades of National Suicide Prevention Policies Haven’t Slowed the Deaths
Pooja Mehta's brother, Raj, died by suicide in March 2020, leaving her…
Intravenous golimumab shows long-term benefit for juvenile idiopathic arthritis
The long-term extension study found that intravenous golimumab for polyarticular-course juvenile idiopathic…
Most recalled heart devices weren’t tested in patients
In 2022, Medtronic recalled over 85,000 implantable defibrillators due to a technical…
Timing embryo transfers during assisted reproduction
In assisted reproductive technology, the timing of embryo transfer after oocyte retrieval…
New treatment extends ovarian function in older mice
A study conducted by Northwestern Medicine in mice has discovered a way…